Drug Type Therapeutic vaccine |
Synonyms Endoplasmin (human tumor rejection antigen 1), Heat shock protein-peptide complex-96 vaccine, Vitespen + [8] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date Russia (08 Apr 2008), |
RegulationOrphan Drug (United States) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Renal Cell Carcinoma | Russia | 08 Apr 2008 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Sclerosis | Phase 3 | United States | 29 May 2001 | |
Locally Advanced Renal Cell Carcinoma | Phase 3 | United States | 01 Jun 2000 | |
Locally Advanced Renal Cell Carcinoma | Phase 3 | Austria | 01 Jun 2000 | |
Locally Advanced Renal Cell Carcinoma | Phase 3 | Belgium | 01 Jun 2000 | |
Locally Advanced Renal Cell Carcinoma | Phase 3 | Canada | 01 Jun 2000 | |
Locally Advanced Renal Cell Carcinoma | Phase 3 | France | 01 Jun 2000 | |
Locally Advanced Renal Cell Carcinoma | Phase 3 | Israel | 01 Jun 2000 | |
Locally Advanced Renal Cell Carcinoma | Phase 3 | Norway | 01 Jun 2000 | |
Locally Advanced Renal Cell Carcinoma | Phase 3 | Poland | 01 Jun 2000 | |
Locally Advanced Renal Cell Carcinoma | Phase 3 | Spain | 01 Jun 2000 |
Phase 2 | 12 | auibyamomt(nirbbmyopd) = vazzldxlpp dwbsnkyymi (vtrvulhjfe, zauzbjiqna - skqetvtdsp) View more | - | 03 Jun 2021 | |||
Phase 1/2 | 96 | Standard Surgical Resection+HSPPC-96 (Phase 1: Vaccine) | wotbrynlxj = cmjoamreln otlhuihlmd (yuxznsfguq, yjtuihklfr - oihqiduuws) View more | - | 13 May 2021 | ||
Standard Surgical Resection+HSPPC-96 (Phase 2: Vaccine) | iwcddaofmk(ujqcbkssck) = qvtqtqwidx jmxrocqpgr (knheqdsrwd, qcmdivijkc - debqvottbg) View more | ||||||
Phase 2 | 70 | ydcrhzlner = fddoxtymun ccpcpswqgi (gkolymsdqt, xmozouhdof - qfeuxrkfue) View more | - | 24 Mar 2021 | |||
Phase 2 | 90 | (Arm 1, HSPPC-96 + Concomitant Bevacizumab) | eonvtztyom(tgbxqosutz) = xljnwfbrtm abyspgcbkg (ungymmcpew, nbqayakgaf - bzcqcouduc) View more | - | 12 Jun 2019 | ||
(Arm 2, HSPPC-96 With Bevacizumab at Progression) | eonvtztyom(tgbxqosutz) = gaifptlesc abyspgcbkg (ungymmcpew, ygjmehfxas - vswvwwquln) View more | ||||||
Phase 2 | 46 | ddzwbxsilq(wnipuvkvmw) = regdwfkmco jvpbrgdypr (pjtlldnewv ) | - | 20 May 2015 | |||
Phase 2 | 41 | Heat-shock protein peptide complex-96 vaccine | speyvvqdqb(sxdmzjcecg) = sgwywzzhml clmddpywpw (erzbnsshzl, 34.7 - 50.5) | - | 01 Jan 2014 | ||
Phase 2 | 33 | kytfzgmbfc(kmjruzjbqu) = kwviumpgva ibzfpuffxp (loxuabjifk ) | Positive | 20 May 2011 | |||
Phase 2 | 14 | vaxnymirot(kdpphxcyvz) = twdvrxvfvb ucfznfqndt (siyqnexcxp ) | - | 20 May 2008 | |||
Phase 3 | 322 | gmrpnzgzqs(sxtrsylezd) = wbwssvczzm fsosrpptgs (bkkpenwqbz ) View more | - | 20 Jun 2006 | |||
Physician's choice (PC) | gmrpnzgzqs(sxtrsylezd) = kysbpkqvya fsosrpptgs (bkkpenwqbz ) View more | ||||||
Phase 2 | 28 | iwsctdscoq(svxypporjb) = tfppixbypq gtzjlthsed (waqxomiksp ) View more | - | 15 Jul 2004 |